Literature DB >> 24043448

Are HPV vaccination services accessible to high-risk communities? A spatial analysis of HPV-associated cancer and Chlamydia rates and safety-net clinics.

Jennifer Tsui1, Hector P Rodriguez, Gilbert C Gee, Loraine A Escobedo, Gerald F Kominski, Roshan Bastani.   

Abstract

PURPOSE: While HPV vaccines can greatly benefit adolescents and young women from high-risk areas, little is known about whether safety-net immunization services are geographically accessible to communities at greatest risk for HPV-associated diseases. We explore the spatial relationship between areas with high HPV risk and proximity to safety-net clinics from an ecologic perspective.
METHODS: We used cancer registry data and Chlamydia surveillance data to identify neighborhoods within Los Angeles County with high risk for HPV-associated cancers. We examined proximity to safety-net clinics among neighborhoods with the highest risk. Proximity was measured as the shortest distance between each neighborhood center and the nearest clinic and having a clinic within 3 miles of each neighborhood center.
RESULTS: The average 5-year non-age-adjusted rates were 1,940 cases per 100,000 for Chlamydia and 60 per 100,000 for HPV-associated cancers. A large majority, 349 of 386 neighborhoods with high HPV-associated cancer rates and 532 of 537 neighborhoods with high Chlamydia rates, had a clinic within 3 miles of the neighborhood center. Clinics were more likely to be located within close proximity to high-risk neighborhoods in the inner city. High-risk neighborhoods outside of this urban core area were less likely to be near accessible clinics.
CONCLUSIONS: The majority of high-risk neighborhoods were geographically near safety-net clinics with HPV vaccination services. Due to low rates of vaccination, these findings suggest that while services are geographically accessible, additional efforts are needed to improve uptake. Programs aimed to increase awareness about the vaccine and to link underserved groups to vaccination services are warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043448      PMCID: PMC3842032          DOI: 10.1007/s10552-013-0286-x

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  57 in total

1.  Parental acceptance of adolescent vaccines within school-based health centres.

Authors:  Mary B Short; Richard Rupp; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Herpes       Date:  2005-06

2.  Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.

Authors:  May Lau; Hua Lin; Glenn Flores
Journal:  Vaccine       Date:  2012-03-15       Impact factor: 3.641

3.  Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination.

Authors:  Marc Brisson; Mélanie Drolet; Talía Malagón
Journal:  J Natl Cancer Inst       Date:  2013-01-07       Impact factor: 13.506

4.  Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls.

Authors:  Roshan Bastani; Beth A Glenn; Jennifer Tsui; L Cindy Chang; Erica J Marchand; Victoria M Taylor; Rita Singhal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-20       Impact factor: 4.254

5.  Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists.

Authors:  Jennifer L Young; Ruth G Bernheim; Jeffrey E Korte; Mark H Stoler; Thomas M Guterbock; Laurel W Rice
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-09-09       Impact factor: 1.814

6.  Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Authors:  Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

7.  Update of HPV-associated female genital cancers in the United States, 1999-2004.

Authors:  Meg Watson; Mona Saraiya; Xiaocheng Wu
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

8.  Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?

Authors:  Daixin Yin; Cyllene Morris; Mark Allen; Rosemary Cress; Janet Bates; Lihua Liu
Journal:  Cancer Causes Control       Date:  2010-06-22       Impact factor: 2.506

9.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

10.  Sociodemographic factors associated with high-risk human papillomavirus infection.

Authors:  Jessica A Kahn; Dongmei Lan; Robert S Kahn
Journal:  Obstet Gynecol       Date:  2007-07       Impact factor: 7.661

View more
  4 in total

1.  HPV Vaccine Awareness, Barriers, Intentions, and Uptake in Latina Women.

Authors:  Julia Lechuga; Lina Vera-Cala; Ana Martinez-Donate
Journal:  J Immigr Minor Health       Date:  2016-02

2.  Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs.

Authors:  Paolo Capogrosso; Eugenio Ventimiglia; Rayan Matloob; Michele Colicchia; Alessandro Serino; Giulia Castagna; Maria Chiara Clementi; Giovanni La Croce; Umberto Capitanio; Giorgio Gandaglia; Rocco Damiano; Vincenzo Mirone; Francesco Montorsi; Andrea Salonia
Journal:  World J Urol       Date:  2014-09-02       Impact factor: 4.226

3.  Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.

Authors:  Parth D Shah; Justin G Trogdon; Shelley D Golden; Carol E Golin; Macary Weck Marciniak; Noel T Brewer
Journal:  Milbank Q       Date:  2018-09       Impact factor: 4.911

4.  Associations Between Exposure to and Expression of Negative Opinions About Human Papillomavirus Vaccines on Social Media: An Observational Study.

Authors:  Adam G Dunn; Julie Leask; Xujuan Zhou; Kenneth D Mandl; Enrico Coiera
Journal:  J Med Internet Res       Date:  2015-06-10       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.